SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-21-006305
Filing Date
2021-05-26
Accepted
2021-05-26 17:02:30
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brpa_13da.htm SC 13D/A 111537
2 MERGER AGREEMENT, DATED AS OF DECEMBER 13, 2020, BY AND AMONG BIG ROCK PARTNERS brpa_ex107.htm EX-10.7 982651
3 SPONSOR AGREEMENT, DATED AS OF MAY 24, 2021, BY AND AMONG BIG ROCK PARTNERS ACQU brpa_ex108.htm EX-10.8 29068
4 AMENDMENT TO STOCK ESCROW AGREEMENT, DATED AS OF MAY 24, 2021, BY AND AMONG BIG brpa_ex109.htm EX-10.9 70254
5 FORM OF UNIT PURCHASE OPTION, DATED NOVEMBER 20, 2017. brpa_ex110.htm EX-10.10 128922
  Complete submission text file 0001654954-21-006305.txt   1324093
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Subject) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90195 | Film No.: 21967239
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2645 N. FEDERAL HIGHWAY SUITE 230 DELRAY BEACH FL 33483
Business Address 2645 N. FEDERAL HIGHWAY SUITE 230 DELRAY BEACH FL 33483 3107342300
Big Rock Partners Sponsor, LLC (Filed by) CIK: 0001723217 (see all company filings)

IRS No.: 822854805 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A